
Independent urology practices head into 2027 facing a conversion factor cut, prior authorization hurdles, and Part B drug price negotiation, according to Gary Kirsh, MD.
Mark Painter, CEO of PRS Urology, and Jonathan Rubenstein, MD, a urologist in Baltimore and member of the AUA’s Coding and Reimbursement Committee, recommend this checklist for ICD-10 urology practice transition.
Mark Painter, CEO of PRS Urology, and Jonathan Rubenstein, MD, a urologist in Baltimore and member of the AUA’s Coding and Reimbursement Committee, recommend this checklist for





